130. Psychedelics and Women's Health with Dr Grace Blest-Hopley episode artwork

EPISODE · May 21, 2025 · 1H 1M

130. Psychedelics and Women's Health with Dr Grace Blest-Hopley

from The Drug Science Podcast · host Drug Science

Join us in the latest episode of the Drug Science Podcast, where we talk with Dr. Grace Blest-Hopley, Director of Research for Heroic Hearts Project UK, Chief Scientific Officer of NW PharmaTech, and founder and CEO of Hystelica. In the episode, she explore where psychedelic studies have largely ignored women’s physiology, particularly in failing to acknowledge and control for hormonal fluctuations. Grace particularly emphasises the necessity for greater investigations and understandings around the intersection of psychedelics and the menstrual cycle, explaining how Hystelica attempts to bridge this gap with naturalistic and observational studies. Throughout, the discussion examines how, by researching these unknowns, we can discover new treatment opportunities that better serve women’s health.Heroic Hearts Project UK HystelicaNWPharmaTech MDMAPsilocybin Retreats Study Mothers of the mushroom Microdosing Study ★ Support this podcast ★

Episode metadata supplied by the publisher feed · Published May 21, 2025

Embed this episode

Ready to play

130. Psychedelics and Women's Health with Dr Grace Blest-Hopley

0:00 1:01:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Drug Science Podcast?

This episode is 1 hour and 1 minute long.

When was this The Drug Science Podcast episode published?

This episode was published on May 21, 2025.

Can I download this The Drug Science Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!